Erythrocyte zinc, copper, and copper/zinc superoxide dismutase and risk of sporadic amyotrophic lateral sclerosis: a population-based case-control study

References

• Mitchell JD. Amyotrophic lateral sclerosis: toxins and environment. Amyotroph Lateral Scler Other Motor Neuron Disord 2000;1:235–50.
   PubMed Web of Science ®Google Scholar
• Julien IP. Amyotrophic lateral sclerosis, unfolding the toxic-ity of the misfolded. Cell 2001; 104:581–591.
   PubMed Web of Science ®Google Scholar
• Rotilio G, Card MT, Ferri A, Gabbianelli R. Superoxide dis-mutase and amyotrophic lateral sclerosis. Free Radicals in Brain Pathophysiology. New York: Marcel Dekker, 2000: 393–409.
   Google Scholar
• Maier CM, Chan PH. Role of superoxide dismutases in oxidative damage and neurodegenerative disorders. Neuro-scientist 2002; 8: 323–334.
   Google Scholar
• Elliott JL. Zinc and copper in the pathogenesis of amy-otrophic lateral sclerosis. Prog Neuropsychopharmacol Biol Psychiatry 2001; 25: 1169–1185.
   PubMed Web of Science ®Google Scholar
• Perry G, Sayre LM, Atwood CS, et al. The role of iron and copper in the etiology of neurodegenerative disorders: thera-peutic implications. CNS Drugs 2002; 16: 339–352.
   PubMed Web of Science ®Google Scholar
• Brooks BR. El Escorial World Federation of Neurology crite-ria for the diagnosis of amyotrophic lateral sclerosis. Sub-committee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial “Clin-ical limits of amyotrophic lateral sclerosis” workshop con-tributors. J Neurol Sci 1994; 124 Suppl: 96–107.
   Google Scholar
• Vinceti M, Guidetti D, Pinotti M, et al. Amyotrophic lateral sclerosis after long-term exposure to drinking water with high selenium content. Epidemiology 1996; 7: 529–532.
   PubMed Web of Science ®Google Scholar
• Guidetti D, Bondavalli M, Sabadini R, et al. Epidemiological survey of amyotrophic lateral sclerosis in the province of Reggio Emilia, Italy: influence of environmental exposure to lead. Neuroepidemiology 1996; 15: 301–312.
   PubMed Web of Science ®Google Scholar
• The Amyotrophic Lateral Sclerosis Functional Rating Scale. Assessment of activities of daily living in patients with amy-otrophic lateral sclerosis. The ALS CNTF treatment study (ACTS) phase MI Study Group. Arch Neurol 1996; 53: 141–147.
   Google Scholar
• Bergomi M, Vinceti M, Nacci G, et al. Environmental expo-sure to trace elements and risk of amyotrophic lateral scler-osis: a population-based case-control study. Environ Res 2002; 89: 116–123.
   PubMed Web of Science ®Google Scholar
• Sun Y, Oberley LW, Li Y. A simple method for clinical assay of superoxide dismutase. Clin Chem 1988; 34: 497–500.
   PubMed Web of Science ®Google Scholar
• Bergomi M, Rovesti S, Vinceti M, Vivoli R, Caselgrandi E, Vivoli G. Zinc and copper status and blood pressure. I Trace Elem Med Biol 1997; 11: 166–169.
   PubMed Web of Science ®Google Scholar
• Rosen DR, Siddique T, Patterson D, et al. Mutations in Cu/Zn superoxide dismutase gene are associated with famil-ial amyotrophic lateral sclerosis. Nature 1993; 362: 59–62.
   PubMed Web of Science ®Google Scholar
• Andersen PM, Nilsson P, Forsgren L, Marklund SL. CuZn-superoxide dismutase, extracellular superoxide dismutase, and glutathione peroxidase in blood from individuals homozygous for Asp90AIa CuZu-superoxide dismutase mutation. I Neurochem 1998; 70: 715–720.
   PubMed Web of Science ®Google Scholar
• Mase G, Ros S, Gemma A, et al. ALS with variable pheno-types in a six-generation family caused by leul44phe muta-tion in the SOD1 gene. J Neurol Sci 2001; 191: 11–18.
   PubMed Web of Science ®Google Scholar
• Kato M, Aoki M, Ohta M, et al. Marked reduction of the Cu/Zn superoxide dismutase polypeptide in a case of famil-ial amyotrophic lateral sclerosis with the homozygous muta-tion. Neurosci Lett 2001; 312: 165–168.
   PubMed Web of Science ®Google Scholar
• SugawaraT, Lewen A, Gasche Y, Yu F, Chan PH. Overexpres-sion of SOD 1 protects vulnerable motor neurons after spinal cord injury by attenuating mitochondrial cytochrome c release. FASEB J (in press).
   Google Scholar
• Borg I, London I. Copper/zinc superoxide dismutase overex-pression promotes survival of cortical neurons exposed to neurotoxins in vitro.) Neurosci Res 2002; 70: 180–189.
   Web of Science ®Google Scholar
• Cleveland DW, Liu J. Oxidation versus aggregation -how do SOD1 mutants cause ALS? Nat Med 2000; 6: 1320–1321.
   PubMed Web of Science ®Google Scholar
• Cookson MR, Menzies FM, Manning P, et al. Cu/Zn superox-ide dismutase (SOD1) mutations associated with familial amyotrophic lateral sclerosis (ALS) affect cellular free radical release in the presence of oxidative stress. Amyotroph Lateral Scler Other Motor Neuron Disord 2002; 3: 75–85.
   PubMed Web of Science ®Google Scholar
• Lino MM, Schneider C, Caroni P. Accumulation of SOD! mutants in postnatal motoneurons does not cause motoneu-ron pathology or motoneuron disease. J Neurosci 2002; 22: 4825–4832.
   PubMed Web of Science ®Google Scholar
• Lee JP, Gerin C, Bindokas VP, Miller R, Ghadge G, Roos RP. No correlation between aggregates of Cu/Zn superoxide dis-mutase and cell death in familial amyotrophic lateral scler-osis.) Neurochem 2002; 82: 1229–1238.
   PubMed Web of Science ®Google Scholar
• Rakhit R, Cunningham P, Furtos-Matei A, et al. Oxidation-induced misfolding and aggregation of superoxide dismu-tase and its implications for amyotrophic lateral sclerosis.) Biol Chem (in press).
   Google Scholar
• Subramaniam JR, Lyons WE, Liu J, et al. Mutant SOD1 causes motor neuron disease independent of copper chaper-one-mediated copper loading. Nat Neurosci 2002; 5: 301–307.
   PubMed Web of Science ®Google Scholar
• Orr HT. A proposed mechanism of ALS fails the test in vivo. Nat Neurosci 2002; 5: 287–288.
   PubMed Web of Science ®Google Scholar
• Iwasaki Y, Ikeda K, Kinoshita M. Decreased cerebrospinal fluid superoxide dismutase in amyotrophic lateral sclerosis. Lancet 1993; 342: 1118.
   PubMed Web of Science ®Google Scholar
• Uchino M, Ando Y, Tanaka Y, et al. Decrease in Cu/Zn-and Mn-superoxide dismutase activities in brain and spinal cord of patients with amyotrophic lateral sclerosis. J Neurol Sci 1994; 127:61–67.
   PubMed Web of Science ®Google Scholar
• Bergeron C, Muntasser S, Somerville MJ, Weyer L, Percy ME. Copper/zinc superoxide dismutase mRNA levels are increased in sporadic amyotrophic lateral sclerosis motorneurons. Brain Res 1994; 659: 272–276.
   PubMed Web of Science ®Google Scholar
• Shaw IC, Fitzmaurice PS, Mitchell JD, Lynch PG. Studies on cellular free radical protection mechanisms in the anterior horn from patients with amyotrophic lateral sclerosis. Neu-rodegeneration 1995; 4: 391–396.
   PubMedGoogle Scholar
• Blaauwgeers HG, Vianney de long JM, Verspaget HW, van den Berg FM, Troost D. Enhanced superoxide dismutase-2 immunoreactivity of astrocytes and occasional neurons in amyotrophic lateral sclerosis. I Neurol Sci 1996; 140: 21–29.
   Google Scholar
• Shibata N, Asayama K, Hirano A, Kobayashi M. Immunohis-tochemical study on superoxide dismutases in spinal cords from autopsied patients with amyotrophic lateral sclerosis. Dev Neurosci 1996; 18; 492–498.
   PubMed Web of Science ®Google Scholar
• Przedborski S, Donaldson DM, Murphy PL, et al. Blood superoxide dismutase, catalase and glutathione peroxidase activities in familial and sporadic amyotrophic lateral scler-osis. Neurodegeneration 1996; 5: 57–64.
   PubMedGoogle Scholar
• Oteiza PI, Uchitel OD, Carrasquedo F, Dubrovski AL, Roma JC, Fraga CG. Evaluation of antioxidants, protein, and lipid oxidation products in blood from sporadic amyotrophic lateral sclerosis patients. Neurochem Res 1997; 22: 535–539.
   PubMed Web of Science ®Google Scholar
• Mitchell JD, Gatt JA, Phillips TM, et al. Cu/Zn superoxide dismutase free radicals, and motoneuron disease. Lancet 1993,342: 1051–1052.
   Google Scholar
• Puymirat J, Cossette L, Gosselin F, Bouchard JP. Red blood cell Cu/Zn superoxide dismutase activity in sporadic amy-otrophic lateral sclerosis. J Neurol Sci 1994; 127: 121–123.
   PubMed Web of Science ®Google Scholar
• Robberecht W, Sapp P, Viaene MK, et al. Cu/Zn superoxide dismutase activity in familial and sporadic amyotrophic lateral sclerosis. J Neurochem 1994; 62: 384–387.
   PubMed Web of Science ®Google Scholar
• Fiszman ML, Borodinsky LN, Ricart KC, Sanz OP, Sica RE. Cu/Zn superoxide dismutase activity at different ages in sporadic amyotrophic lateral sclerosis. J Neurol Sci 1999; 162:34–37.
   PubMed Web of Science ®Google Scholar
• Torsdottir G, Kristinsson), Gudmundsson G, Snaedal J, Johannesson T. Copper, ceruloplasmin and superoxide dis-mutase (SOD) in amyotrophic lateral sclerosis. Pharmacol Toxicol 2000; 87: 126–130.
   Google Scholar
• Bowling AC, Barkowski EE, McKenna-Yasek D, et al. Super-oxide dismutase concentration and activity in familial amy-otrophic lateral sclerosis. J Neurochem 1995; 64: 2366–2369.
   PubMed Web of Science ®Google Scholar
• O’Reilly SA, Roedica], Nagy D, et al. Motor neuron-astrocyte interactions and levels of Cu,Zn superoxide dismutase in sporadic amyotrophic lateral sclerosis. Exp Neurol 1995; 131:203–210.
   Google Scholar
• lhara Y, Mori A, Hayabara T, et al. Superoxide dismutase and free radicals in sporadic amyotrophic lateral sclerosis: rela-tionship to clinical data. J Neurol Sci 1995; 134: 51–56.
   Google Scholar
• Cohen O, Kohen R, Lavon E, Abramsky O, Steiner 1. Serum Cu/Zn superoxide dismutase activity is reduced in sporadic amyotrophic lateral sclerosis patients.) Neurol Sci 1996; 143: 118–120.
   Google Scholar
• Reiser S, Smith]C Jr, Mertz W, et al. Indices of copper status in humans consuming a typical American diet containing either fructose or starch. Am I Clin Nutr 1985; 42: 242–251.
   Google Scholar
• Iwasaki Y, Shiojima T, Kinoshita M. Superoxide dismutase activity in amyotrophic lateral sclerosis.) Neurol Sci 1997; 152:226–229.
   Web of Science ®Google Scholar
• Bruce B, Spiller GA, Klevay LM, Gallagher SK. A diet high in whole and unrefined foods favorably alters lipids, antioxi-dant defenses, and colon function. J Am Coll Nutr 2000; 19: 61–67.
   PubMed Web of Science ®Google Scholar
• Nadif R, Bourgkard E, Dusch M, et al. Relations between occupational exposure to coal mine dusts, erythrocyte cata-lase and Cu++/Zn++ superoxide dismutase activities, and the severity of coal workers’ pneumoconiosis. Occup Environ Med 1998;55:533–540.
   PubMed Web of Science ®Google Scholar
• Panemangalore M, Dowla HA, Byers ME. Occupational exposure to agricultural chemicals: effect on the activities of some enzymes in the blood of farm workers. Int Arch Occup Environ Health 1999; 72: 84–88.
   PubMed Web of Science ®Google Scholar
• Jian L, Hu D. Antioxidative stress response in workers exposed to carbon disulfide. Int Arch Occup Environ Health 2000; 73: 503–506.
   PubMed Web of Science ®Google Scholar
• Ceballos-Picot I, Trivier JM, Nicole A, Sinet PM, Thevenin M. Age-correlated modifications of copper-zinc superoxide dis-mutase and glutathione-related enzyme activities in human erythrocytes. Clin Chem 1992; 38: 66–70.
   PubMed Web of Science ®Google Scholar
• WHO. Trace elements in human nutrition and health. Geneva: World Health Organization, 1996.
   Google Scholar
• Garcia-Redondo A, Bustos F, Juan Y Seva B, et al. Molecular analysis of the superoxide dismutase 1 gene in Spanish patients with sporadic or familial amyotrophic lateral scler-osis. Muscle Nerve 2002; 26: 274–278.
   Google Scholar
• Llanos RM, Mercer JF. The molecular basis of copper home-ostasis copper-related disorders. DNA Cell Biol 2002; 21: 259–270.
   PubMed Web of Science ®Google Scholar
• Radunovic A, Delves HT, Robberecht W, et al. Copper and zinc levels in familial amyotrophic lateral sclerosis patients with CuZnSOD gene mutations. Ann Neurol 1997; 42: 130–131.
   PubMed Web of Science ®Google Scholar
• Pamphlett R, McQuilty R, Zarkos K. Blood levels of toxic and essential metals in motor neuron disease. Neurotoxicology 2001;22:401–410.
   PubMed Web of Science ®Google Scholar